
Acetylcholine is a predominant excitatory neurotransmitter in the gastrointestinal (GI) tract and targets M 2 and M 3 receptors. We used cell-specific, conditional M 3 knockout mice and found that responses to cholinergic neurotransmission in gastric fundus were unaffected in smooth muscle cell knockouts and greatly depressed in knockouts in interstitial cells of Cajal (ICCs). The results suggest that responses to cholinergic neurotransmission are mediated through M 3 receptors expressed by ICCs and not directly through SMCs.
Introduction: Necrotizing Enterocolitis (NEC) is a gastrointestinal emergency in premature neonates. Its multifactorial pathogenesis includes increased permeability and dysregulated inflammation. Caveolin-1 regulates intestinal permeability via endocytosis and trafficking of tight junction proteins, specifically occludin. We hypothesize that caveolin-1 expression is altered in NEC leading to decreased tight junction protein trafficking and increased intestinal permeability. Methods: Wild-type and caveolin-1 knockout mice underwent experimental NEC for survival analysis followed by tissue harvest for histologic evaluation, permeability assay, RNA and protein extraction, immunohistochemistry, and enteroid generation. Enteroids derived from wild-type and caveolin-1 knockout mice underwent experimental NEC followed by permeability assay and RNA extraction for RT-qPCR. Additionally, tissue from human patients with and without active NEC underwent protein extraction for western blot and immunofluorescent staining. Results: Caveolin-1 knockout mice had worsened experimental NEC on gross and histologic analysis compared to wild-type and decreased survival (p<0.05,p=0.003). Caveolin-1 knockout enteroids had increased permeability following experimental NEC (p=0.022, p=0.006). Occludin localization was more disorganized and expression was decreased in experimental caveolin-1 knockout mice compared to wild-type (p=0.002). Caveolin-1 and occludin protein was found to be decreased in active human NEC tissue compared to control (p=0.004, p=0.025). Conclusion: Caveolin-1 deficiency is associated with decreased survival and more severe histologic disease in a mouse model of NEC. Caveolin-1 expression is decreased in NEC, which correlates with a decrease in occludin expression and resultant increase in intestinal permeability. Our work suggests caveolin-1 deficiency may lead to a predisposition to increased permeability in response to NEC.
We explored how a dietary intervention with fructose in the drinking water and added cholesterol to a high-fat diet, extensively used to induce obesity, glucose intolerance, and insulin resistance, promotes metabolic dysfunction-associated steatotic liver disease (MASLD) with obesity and metabolic dysfunction in male and female mice. This model of MASLD shows increased expression of hepatocyte peroxisome proliferator-activated receptor γ (PPARγ) in both male and female mice, but only male mice develop hepatocyte PPARγ-dependent metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis.
This study identifies the colon as a metabolically active tissue affected in metabolic syndrome. Despite the absence of intestinal inflammation, MS NASH mice displayed altered colonic metabolism and microbiota composition, with conserved metabolite changes matching those seen in humans with metabolic syndrome. These findings highlight colonic metabolic dysfunction as a potential driver of gut dysbiosis and disease progression in metabolic syndrome and metabolic dysfunction-associated steatotic liver disease (MASLD).
We present a compartmentalized microfluidic trichannel model of the gut-brain axis that reveals how microbial metabolites communicate with neurons. Using this model, we show that butyrate triggers colonic serotonin release, which activates neuronal signaling through calcium influx. This work highlights the power of microfluidic models to uncover mechanisms of gut-brain communication in a controlled, in vitro setting.